Early Antibiotic Discontinuation in Patients With Clinically Suspected Ventilator-Associated Pneumonia and Negative Quantitative Bronchoscopy Cultures

OBJECTIVES:Preliminary data suggest that antibiotic discontinuation in patients with negative quantitative bronchoscopy and symptom resolution will not increase mortality. Because our hospital algorithm for antibiotic discontinuation rules out ventilator-associated pneumonia in the setting of negati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care medicine 2013-07, Vol.41 (7), p.1656-1663
Hauptverfasser: Raman, Kirthana, Nailor, Michael D, Nicolau, David P, Aslanzadeh, Jaber, Nadeau, Michelle, Kuti, Joseph L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1663
container_issue 7
container_start_page 1656
container_title Critical care medicine
container_volume 41
creator Raman, Kirthana
Nailor, Michael D
Nicolau, David P
Aslanzadeh, Jaber
Nadeau, Michelle
Kuti, Joseph L
description OBJECTIVES:Preliminary data suggest that antibiotic discontinuation in patients with negative quantitative bronchoscopy and symptom resolution will not increase mortality. Because our hospital algorithm for antibiotic discontinuation rules out ventilator-associated pneumonia in the setting of negative quantitative bronchoscopy cultures, we compared antibiotic utilization and mortality in empirically treated, culture-negative ventilator-associated pneumonia patients whose antibiotic discontinuation was early versus late. DESIGN:Retrospective, observational cohort study. SETTING:Eight hundred sixty-seven bed, tertiary care, teaching hospital in Hartford, CT. PATIENTS:Eighty-nine patients with clinically suspected ventilator-associated pneumonia and a negative (
doi_str_mv 10.1097/CCM.0b013e318287f713
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1369718512</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1369718512</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3863-86bb293bd04f15becc5512d75d9fea491e74f20272bbe287f560202b8f53fedc3</originalsourceid><addsrcrecordid>eNp9kU2PFCEQhonRuOPqPzCGi4mXXqFpBvo4tutqsuoav44doKsdlIFZPtzMH9nfK5MZNfHgCap46i2qXoQeU3JGSS-eD8PbM6IJZcCobKWYBWV30IJyRhrS9uwuWhDSk4Z1PTtBD1L6TgjtuGD30UnLeCsl4Qt0e66i2-GVz1bbkK3BL20yoYa-qGyDx9bjq3oDnxP-avMaD856a5SrZR9L2oLJMOEv9d06lUNsVikFY9U-e-WhbIK3Cis_4XfwrQr9BPyhqErnQ_AiBm_WoTbd7vBQXC4R0kN0b1YuwaPjeYo-vzr_NLxuLt9fvBlWl41hcskaudS6jqon0s2UazCGc9pOgk_9DKrrKYhubkkrWq1hvyO-JDXUcuZshsmwU_TsoLuN4bpAyuOmjg_OKQ-hpJGyZS-orKIV7Q6oiSGlCPO4jXaj4m6kZNw7MlZHxn8dqWVPjh2K3sD0p-i3BRV4egRUqludo_LGpr-c6CRp2V5IHrib4DLE9MOVG4jjGpTL6___4RcDHqpb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1369718512</pqid></control><display><type>article</type><title>Early Antibiotic Discontinuation in Patients With Clinically Suspected Ventilator-Associated Pneumonia and Negative Quantitative Bronchoscopy Cultures</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Raman, Kirthana ; Nailor, Michael D ; Nicolau, David P ; Aslanzadeh, Jaber ; Nadeau, Michelle ; Kuti, Joseph L</creator><creatorcontrib>Raman, Kirthana ; Nailor, Michael D ; Nicolau, David P ; Aslanzadeh, Jaber ; Nadeau, Michelle ; Kuti, Joseph L</creatorcontrib><description>OBJECTIVES:Preliminary data suggest that antibiotic discontinuation in patients with negative quantitative bronchoscopy and symptom resolution will not increase mortality. Because our hospital algorithm for antibiotic discontinuation rules out ventilator-associated pneumonia in the setting of negative quantitative bronchoscopy cultures, we compared antibiotic utilization and mortality in empirically treated, culture-negative ventilator-associated pneumonia patients whose antibiotic discontinuation was early versus late. DESIGN:Retrospective, observational cohort study. SETTING:Eight hundred sixty-seven bed, tertiary care, teaching hospital in Hartford, CT. PATIENTS:Eighty-nine patients with clinically suspected ventilator-associated pneumonia and a negative (&lt;10 colony forming units/mL) quantitative bronchoscopy culture between January 2009 and March 2012. Early discontinuation patients (n = 40) were defined as those who had all antibiotic therapy stopped within one day of final negative culture report, whereas late discontinuation patients (n = 49) had antibiotics stopped later than one day. MEASUREMENTS:Univariate analyses assessed mortality, antibiotic duration, and frequency of superinfections. Multivariate logistic regression was performed to assess the effect of early discontinuation on hospital mortality. RESULTS:Patients had a mean ± SD Acute Physiology and Chronic Health Evaluation II score of 26.0 ± 6.0. Mortality was not different between early discontinuation (25.0%) and late discontinuation (30.6%) patients (p = 0.642). Antibiotic duration (days) was also not different for patients who died vs. those who survived (Median [interquartile range]3 [1–7.5] vs. 3 [1.75–6.25], respectively, p = 0.87), and when controlling for baseline characteristics and symptom resolution, only Acute Physiology and Chronic Health Evaluation II score was associated with hospital mortality on multivariate analyses. There were fewer superinfections (22.5% vs. 42.9%, p = 0.008), respiratory superinfections (10.0% vs. 28.6%, p = 0.036), and multidrug resistant superinfections (7.5% vs. 35.7%, p = 0.003), in early discontinuation compared with late discontinuation patients. CONCLUSIONS:In this severely ill population with clinically suspected ventilator-associated pneumonia and negative quantitative bronchoalveolar lavage cultures, early discontinuation of antibiotics did not affect mortality and was associated with a lower frequency of MDR superinfections.</description><identifier>ISSN: 0090-3493</identifier><identifier>EISSN: 1530-0293</identifier><identifier>DOI: 10.1097/CCM.0b013e318287f713</identifier><identifier>PMID: 23528805</identifier><identifier>CODEN: CCMDC7</identifier><language>eng</language><publisher>Hagerstown, MD: by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</publisher><subject>Aged ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Anti-Bacterial Agents - administration &amp; dosage ; Anti-Bacterial Agents - therapeutic use ; APACHE ; Biological and medical sciences ; Bronchoalveolar Lavage Fluid - microbiology ; Drug Administration Schedule ; Female ; General aspects ; Hospital Mortality ; Hospitals, Teaching ; Human infectious diseases. Experimental studies and models ; Humans ; Infectious diseases ; Intensive care medicine ; Male ; Medical sciences ; Middle Aged ; Pneumonia, Ventilator-Associated - complications ; Pneumonia, Ventilator-Associated - diagnosis ; Pneumonia, Ventilator-Associated - drug therapy ; Retrospective Studies ; Superinfection - etiology</subject><ispartof>Critical care medicine, 2013-07, Vol.41 (7), p.1656-1663</ispartof><rights>2013 by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</rights><rights>2014 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3863-86bb293bd04f15becc5512d75d9fea491e74f20272bbe287f560202b8f53fedc3</citedby><cites>FETCH-LOGICAL-c3863-86bb293bd04f15becc5512d75d9fea491e74f20272bbe287f560202b8f53fedc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=27480233$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23528805$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Raman, Kirthana</creatorcontrib><creatorcontrib>Nailor, Michael D</creatorcontrib><creatorcontrib>Nicolau, David P</creatorcontrib><creatorcontrib>Aslanzadeh, Jaber</creatorcontrib><creatorcontrib>Nadeau, Michelle</creatorcontrib><creatorcontrib>Kuti, Joseph L</creatorcontrib><title>Early Antibiotic Discontinuation in Patients With Clinically Suspected Ventilator-Associated Pneumonia and Negative Quantitative Bronchoscopy Cultures</title><title>Critical care medicine</title><addtitle>Crit Care Med</addtitle><description>OBJECTIVES:Preliminary data suggest that antibiotic discontinuation in patients with negative quantitative bronchoscopy and symptom resolution will not increase mortality. Because our hospital algorithm for antibiotic discontinuation rules out ventilator-associated pneumonia in the setting of negative quantitative bronchoscopy cultures, we compared antibiotic utilization and mortality in empirically treated, culture-negative ventilator-associated pneumonia patients whose antibiotic discontinuation was early versus late. DESIGN:Retrospective, observational cohort study. SETTING:Eight hundred sixty-seven bed, tertiary care, teaching hospital in Hartford, CT. PATIENTS:Eighty-nine patients with clinically suspected ventilator-associated pneumonia and a negative (&lt;10 colony forming units/mL) quantitative bronchoscopy culture between January 2009 and March 2012. Early discontinuation patients (n = 40) were defined as those who had all antibiotic therapy stopped within one day of final negative culture report, whereas late discontinuation patients (n = 49) had antibiotics stopped later than one day. MEASUREMENTS:Univariate analyses assessed mortality, antibiotic duration, and frequency of superinfections. Multivariate logistic regression was performed to assess the effect of early discontinuation on hospital mortality. RESULTS:Patients had a mean ± SD Acute Physiology and Chronic Health Evaluation II score of 26.0 ± 6.0. Mortality was not different between early discontinuation (25.0%) and late discontinuation (30.6%) patients (p = 0.642). Antibiotic duration (days) was also not different for patients who died vs. those who survived (Median [interquartile range]3 [1–7.5] vs. 3 [1.75–6.25], respectively, p = 0.87), and when controlling for baseline characteristics and symptom resolution, only Acute Physiology and Chronic Health Evaluation II score was associated with hospital mortality on multivariate analyses. There were fewer superinfections (22.5% vs. 42.9%, p = 0.008), respiratory superinfections (10.0% vs. 28.6%, p = 0.036), and multidrug resistant superinfections (7.5% vs. 35.7%, p = 0.003), in early discontinuation compared with late discontinuation patients. CONCLUSIONS:In this severely ill population with clinically suspected ventilator-associated pneumonia and negative quantitative bronchoalveolar lavage cultures, early discontinuation of antibiotics did not affect mortality and was associated with a lower frequency of MDR superinfections.</description><subject>Aged</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Anti-Bacterial Agents - administration &amp; dosage</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>APACHE</subject><subject>Biological and medical sciences</subject><subject>Bronchoalveolar Lavage Fluid - microbiology</subject><subject>Drug Administration Schedule</subject><subject>Female</subject><subject>General aspects</subject><subject>Hospital Mortality</subject><subject>Hospitals, Teaching</subject><subject>Human infectious diseases. Experimental studies and models</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pneumonia, Ventilator-Associated - complications</subject><subject>Pneumonia, Ventilator-Associated - diagnosis</subject><subject>Pneumonia, Ventilator-Associated - drug therapy</subject><subject>Retrospective Studies</subject><subject>Superinfection - etiology</subject><issn>0090-3493</issn><issn>1530-0293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU2PFCEQhonRuOPqPzCGi4mXXqFpBvo4tutqsuoav44doKsdlIFZPtzMH9nfK5MZNfHgCap46i2qXoQeU3JGSS-eD8PbM6IJZcCobKWYBWV30IJyRhrS9uwuWhDSk4Z1PTtBD1L6TgjtuGD30UnLeCsl4Qt0e66i2-GVz1bbkK3BL20yoYa-qGyDx9bjq3oDnxP-avMaD856a5SrZR9L2oLJMOEv9d06lUNsVikFY9U-e-WhbIK3Cis_4XfwrQr9BPyhqErnQ_AiBm_WoTbd7vBQXC4R0kN0b1YuwaPjeYo-vzr_NLxuLt9fvBlWl41hcskaudS6jqon0s2UazCGc9pOgk_9DKrrKYhubkkrWq1hvyO-JDXUcuZshsmwU_TsoLuN4bpAyuOmjg_OKQ-hpJGyZS-orKIV7Q6oiSGlCPO4jXaj4m6kZNw7MlZHxn8dqWVPjh2K3sD0p-i3BRV4egRUqludo_LGpr-c6CRp2V5IHrib4DLE9MOVG4jjGpTL6___4RcDHqpb</recordid><startdate>201307</startdate><enddate>201307</enddate><creator>Raman, Kirthana</creator><creator>Nailor, Michael D</creator><creator>Nicolau, David P</creator><creator>Aslanzadeh, Jaber</creator><creator>Nadeau, Michelle</creator><creator>Kuti, Joseph L</creator><general>by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</general><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201307</creationdate><title>Early Antibiotic Discontinuation in Patients With Clinically Suspected Ventilator-Associated Pneumonia and Negative Quantitative Bronchoscopy Cultures</title><author>Raman, Kirthana ; Nailor, Michael D ; Nicolau, David P ; Aslanzadeh, Jaber ; Nadeau, Michelle ; Kuti, Joseph L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3863-86bb293bd04f15becc5512d75d9fea491e74f20272bbe287f560202b8f53fedc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Aged</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Anti-Bacterial Agents - administration &amp; dosage</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>APACHE</topic><topic>Biological and medical sciences</topic><topic>Bronchoalveolar Lavage Fluid - microbiology</topic><topic>Drug Administration Schedule</topic><topic>Female</topic><topic>General aspects</topic><topic>Hospital Mortality</topic><topic>Hospitals, Teaching</topic><topic>Human infectious diseases. Experimental studies and models</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pneumonia, Ventilator-Associated - complications</topic><topic>Pneumonia, Ventilator-Associated - diagnosis</topic><topic>Pneumonia, Ventilator-Associated - drug therapy</topic><topic>Retrospective Studies</topic><topic>Superinfection - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Raman, Kirthana</creatorcontrib><creatorcontrib>Nailor, Michael D</creatorcontrib><creatorcontrib>Nicolau, David P</creatorcontrib><creatorcontrib>Aslanzadeh, Jaber</creatorcontrib><creatorcontrib>Nadeau, Michelle</creatorcontrib><creatorcontrib>Kuti, Joseph L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Raman, Kirthana</au><au>Nailor, Michael D</au><au>Nicolau, David P</au><au>Aslanzadeh, Jaber</au><au>Nadeau, Michelle</au><au>Kuti, Joseph L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early Antibiotic Discontinuation in Patients With Clinically Suspected Ventilator-Associated Pneumonia and Negative Quantitative Bronchoscopy Cultures</atitle><jtitle>Critical care medicine</jtitle><addtitle>Crit Care Med</addtitle><date>2013-07</date><risdate>2013</risdate><volume>41</volume><issue>7</issue><spage>1656</spage><epage>1663</epage><pages>1656-1663</pages><issn>0090-3493</issn><eissn>1530-0293</eissn><coden>CCMDC7</coden><abstract>OBJECTIVES:Preliminary data suggest that antibiotic discontinuation in patients with negative quantitative bronchoscopy and symptom resolution will not increase mortality. Because our hospital algorithm for antibiotic discontinuation rules out ventilator-associated pneumonia in the setting of negative quantitative bronchoscopy cultures, we compared antibiotic utilization and mortality in empirically treated, culture-negative ventilator-associated pneumonia patients whose antibiotic discontinuation was early versus late. DESIGN:Retrospective, observational cohort study. SETTING:Eight hundred sixty-seven bed, tertiary care, teaching hospital in Hartford, CT. PATIENTS:Eighty-nine patients with clinically suspected ventilator-associated pneumonia and a negative (&lt;10 colony forming units/mL) quantitative bronchoscopy culture between January 2009 and March 2012. Early discontinuation patients (n = 40) were defined as those who had all antibiotic therapy stopped within one day of final negative culture report, whereas late discontinuation patients (n = 49) had antibiotics stopped later than one day. MEASUREMENTS:Univariate analyses assessed mortality, antibiotic duration, and frequency of superinfections. Multivariate logistic regression was performed to assess the effect of early discontinuation on hospital mortality. RESULTS:Patients had a mean ± SD Acute Physiology and Chronic Health Evaluation II score of 26.0 ± 6.0. Mortality was not different between early discontinuation (25.0%) and late discontinuation (30.6%) patients (p = 0.642). Antibiotic duration (days) was also not different for patients who died vs. those who survived (Median [interquartile range]3 [1–7.5] vs. 3 [1.75–6.25], respectively, p = 0.87), and when controlling for baseline characteristics and symptom resolution, only Acute Physiology and Chronic Health Evaluation II score was associated with hospital mortality on multivariate analyses. There were fewer superinfections (22.5% vs. 42.9%, p = 0.008), respiratory superinfections (10.0% vs. 28.6%, p = 0.036), and multidrug resistant superinfections (7.5% vs. 35.7%, p = 0.003), in early discontinuation compared with late discontinuation patients. CONCLUSIONS:In this severely ill population with clinically suspected ventilator-associated pneumonia and negative quantitative bronchoalveolar lavage cultures, early discontinuation of antibiotics did not affect mortality and was associated with a lower frequency of MDR superinfections.</abstract><cop>Hagerstown, MD</cop><pub>by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</pub><pmid>23528805</pmid><doi>10.1097/CCM.0b013e318287f713</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-3493
ispartof Critical care medicine, 2013-07, Vol.41 (7), p.1656-1663
issn 0090-3493
1530-0293
language eng
recordid cdi_proquest_miscellaneous_1369718512
source MEDLINE; Journals@Ovid Complete
subjects Aged
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Anti-Bacterial Agents - administration & dosage
Anti-Bacterial Agents - therapeutic use
APACHE
Biological and medical sciences
Bronchoalveolar Lavage Fluid - microbiology
Drug Administration Schedule
Female
General aspects
Hospital Mortality
Hospitals, Teaching
Human infectious diseases. Experimental studies and models
Humans
Infectious diseases
Intensive care medicine
Male
Medical sciences
Middle Aged
Pneumonia, Ventilator-Associated - complications
Pneumonia, Ventilator-Associated - diagnosis
Pneumonia, Ventilator-Associated - drug therapy
Retrospective Studies
Superinfection - etiology
title Early Antibiotic Discontinuation in Patients With Clinically Suspected Ventilator-Associated Pneumonia and Negative Quantitative Bronchoscopy Cultures
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T21%3A37%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20Antibiotic%20Discontinuation%20in%20Patients%20With%20Clinically%20Suspected%20Ventilator-Associated%20Pneumonia%20and%20Negative%20Quantitative%20Bronchoscopy%20Cultures&rft.jtitle=Critical%20care%20medicine&rft.au=Raman,%20Kirthana&rft.date=2013-07&rft.volume=41&rft.issue=7&rft.spage=1656&rft.epage=1663&rft.pages=1656-1663&rft.issn=0090-3493&rft.eissn=1530-0293&rft.coden=CCMDC7&rft_id=info:doi/10.1097/CCM.0b013e318287f713&rft_dat=%3Cproquest_cross%3E1369718512%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1369718512&rft_id=info:pmid/23528805&rfr_iscdi=true